Amsterdam-based consumer health firm Serrix BV has entered a strategic partnership with Dutch company OTC Medical BV to distribute its brands in the Netherlands.
Serrix Strikes Deal With OTC Medical For Netherlands Distribution
OTC Medical is now the distributor in the Netherlands of Serrix’s self-care brands, including fungal nail brand Mycosan, zinc-based cold sore treatment SoreFiX and children’s skincare brand donttellmum.
More from Europe
• By
HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.
• By
“Overall, no unexpected/new data or findings” were presented to Germany's Expert Committee for Prescription in the most recent Rx-to-OTC switch application for sildenafil (25mg and 50mg), according to medicines regulator BfArM, resulting in a third rejection in three years.
• By
“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.
• By
Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.
More from Startups & SMEs
• By
Maxwellia is inviting 100 investors to contribute to the “development of new healthcare solutions that will benefit millions, while also playing a role in shaping the future of self-care.”
• By
In this instalment of HBW Insight’s “Inside Regulatory Affairs” series, AdverCheck managing directors Lucy Rochford and James Walmsley describe how the consumer health industry is increasingly outsourcing its advertising copy review as it moves closer to the fast-moving consumer goods sector. They also point to a worrying trend in the UK of advertising prescription-only medicines online.
• By
Haleon will launch Futura Medical's FDA-approved OTC medical device for erectile dysfunction in the US before the end of the year. Already available to pre-order online on Amazon, Eroxon represents the firm's first move into the sexual health category.